Cargando…
Metabolic syndrome and obesity in peritoneal dialysis
Metabolic syndrome (MS) refers to clustering of features related to increased risk of cardiovascular disease, which include obesity or central obesity, dyslipidemia, diabetes mellitus or insulin resistance, together with hypertension. The prevalence of MS in end-stage renal failure patients on perit...
Autor principal: | Lo, Wai Kei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811989/ https://www.ncbi.nlm.nih.gov/pubmed/27069852 http://dx.doi.org/10.1016/j.krcp.2015.12.007 |
Ejemplares similares
-
Metabolic syndrome in peritoneal dialysis patients
por: Li, Philip Kam-Tao, et al.
Publicado: (2008) -
Peritoneal Dialysis—Moving from Current Status to the Future
por: Oh, Kook-Hwan, et al.
Publicado: (2013) -
Peritoneal dialysis first policy in Hong Kong for 35 years: Global impact
por: Li, Philip Kam‐Tao, et al.
Publicado: (2022) -
Peritoneal dialysis-related peritonitis: challenges and solutions
por: Salzer, William L
Publicado: (2018) -
Continuous Ambulatory Peritoneal Dialysis Peritonitis Guidelines – Consensus Statement of Peritoneal Dialysis Society of India - 2020
por: Jeloka, Tarun K., et al.
Publicado: (2021)